Enjoy Interactive Tools and Indicators
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
| GORMAN KEVIN CHARLES | President and CEO | Feb 28 | Sale | 6.83 | 15,400 | 105,134 | 177,202 | Mar 02 05:06 PM |
| Coughlin Timothy P | VP and Chief Financial Officer | Feb 28 | Sale | 6.83 | 12,320 | 84,104 | 96,124 | Mar 02 05:04 PM |
| VALEUR JENSEN MARGARET E | EVP and General Counsel | Feb 28 | Sale | 6.83 | 12,320 | 84,104 | 118,256 | Mar 02 05:02 PM |
| OBrien Christopher Flint | Sr. VP & Chief Medical Officer | Feb 28 | Sale | 6.83 | 12,320 | 84,091 | 94,794 | Mar 02 05:00 PM |
| Grigoriadis Dimitri E. | Vice President, Research | Feb 28 | Sale | 6.82 | 12,320 | 84,075 | 75,433 | Mar 02 04:59 PM |
| Bozigian Haig P. | Sr Vice President, Development | Feb 28 | Sale | 6.83 | 12,320 | 84,085 | 76,954 | Mar 02 04:56 PM |